Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study.

Area of Science:

• Gastroenterology
• Immunology
• Molecular Biology

Background:

• Colonic eosinophilia, or eosinophilic colitis (EoC), is a poorly understood condition.
• Its relationship to other eosinophilic gastrointestinal diseases (EGIDs) and inflammatory bowel disease (IBD) remains unclear.

Purpose of the Study:

• To define the transcriptomic profile of eosinophilic colitis (EoC).
• To differentiate EoC from other gastrointestinal eosinophilic disorders and inflammatory bowel disease (IBD).

Main Methods:

• RNA sequencing of colon biopsies from patients with EoC, normal controls, and Crohn's disease (CD).
• Analysis of gene expression, correlation with histologic features, and pathway analysis.
• Immunostaining for cell cycle and apoptosis markers.

Main Results:

• Identified 987 differentially expressed genes in EoC, with colonic eosinophil count correlating significantly with specific genes (e.g., CCL11, CLC).
• EoC showed minimal transcriptomic overlap with other EGIDs and lacked a strong type 2 immune response.
• Functional analysis revealed decreased cell cycle and increased apoptosis in EoC; EoC transcriptomic scores differentiated it from IBD.

Conclusions:

• Established distinct transcriptomic profiles for eosinophilic colitis (EoC).
• Demonstrated that EoC is a separate entity from other EGIDs and IBD.
• Findings provide a foundation for improved EoC diagnosis and targeted therapies.